An overview of vaccine development for COVID-19.
COVID-19
COVID-19 vaccines
SARS-CoV-2
Journal
Therapeutic delivery
ISSN: 2041-6008
Titre abrégé: Ther Deliv
Pays: England
ID NLM: 101538870
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
pubmed:
25
2
2021
medline:
30
3
2021
entrez:
24
2
2021
Statut:
ppublish
Résumé
The COVID-19 pandemic continues to endanger world health and the economy. The causative SARS-CoV-2 coronavirus has a unique replication system. The end point of the COVID-19 pandemic is either herd immunity or widespread availability of an effective vaccine. Multiple candidate vaccines - peptide, virus-like particle, viral vectors (replicating and nonreplicating), nucleic acids (DNA or RNA), live attenuated virus, recombinant designed proteins and inactivated virus - are presently under various stages of expansion, and a small number of vaccine candidates have progressed into clinical phases. At the time of writing, three major pharmaceutical companies, namely Pfizer and Moderna, have their vaccines under mass production and administered to the public. This review aims to investigate the most critical vaccines developed for COVID-19 to date.
Identifiants
pubmed: 33624533
doi: 10.4155/tde-2020-0129
pmc: PMC7923686
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
235-244Références
Cureus. 2020 May 28;12(5):e8342
pubmed: 32494546
J Infect. 2005 Oct;51(3):263-5
pubmed: 16045996
J Adv Res. 2020 Mar 16;24:91-98
pubmed: 32257431
Nat Rev Microbiol. 2009 Mar;7(3):226-36
pubmed: 19198616
Curr Trop Med Rep. 2020 Mar 3;:1-4
pubmed: 32219057
Viruses. 2020 Jan 20;12(1):
pubmed: 31968702
Nat Rev Immunol. 2020 Oct;20(10):615-632
pubmed: 32887954
J Biomed Sci. 2020 Jun 4;27(1):72
pubmed: 32498686
Hum Vaccin Immunother. 2020 Jun 2;16(6):1232-1238
pubmed: 32186952
PLoS One. 2015 Dec 07;10(12):e0144475
pubmed: 26641892
Int J Mol Sci. 2020 May 10;21(9):
pubmed: 32397684
J Water Health. 2020 Oct;18(5):613-630
pubmed: 33095188
Virus Res. 2020 Oct 15;288:198114
pubmed: 32800805
Microb Pathog. 2020 Aug;145:104236
pubmed: 32376359
Life Sci. 2020 Aug 1;254:117765
pubmed: 32437797
Anaesth Crit Care Pain Med. 2020 Dec;39(6):703-705
pubmed: 33096260
Antiviral Res. 2016 Sep;133:165-77
pubmed: 27468951
PLoS One. 2019 Jul 22;14(7):e0220196
pubmed: 31329652
J Med Virol. 2013 Jun;85(6):1077-84
pubmed: 23588735
ACS Cent Sci. 2020 Mar 25;6(3):315-331
pubmed: 32226821
J Infect Dis. 2019 Jun 5;220(1):46-56
pubmed: 30796818
Mult Scler Relat Disord. 2020 Sep;44:102249
pubmed: 32526698
Expert Opin Drug Saf. 2020 Jul;19(7):771-774
pubmed: 32442040
Science. 2020 Feb 21;367(6480):
pubmed: 32079747
Pharm Nanotechnol. 2020;8(4):323-353
pubmed: 32811406
Inform Med Unlocked. 2020;20:100374
pubmed: 32835073
J Biosci. 2020;45:
pubmed: 32385219
Maedica (Bucur). 2013 Mar;8(1):53-8
pubmed: 24023600
Nat Rev Drug Discov. 2020 May;19(5):305-306
pubmed: 32273591
Nature. 2020 Oct;586(7830):589-593
pubmed: 32785213
Viruses. 2020 Feb 22;12(2):
pubmed: 32098422
Trends Pharmacol Sci. 2020 Jun;41(6):363-382
pubmed: 32291112
Trop Med Int Health. 2020 Mar;25(3):278-280
pubmed: 32052514
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
Sci Transl Med. 2012 Jan 4;4(115):115ra2
pubmed: 22218691
Expert Opin Ther Targets. 2017 Feb;21(2):131-143
pubmed: 27936982
Cell Mol Immunol. 2020 Jun;17(6):613-620
pubmed: 32203189
Med Sci Monit. 2020 May 05;26:e924700
pubmed: 32366816
Nat Rev Microbiol. 2013 Dec;11(12):836-48
pubmed: 24217413
Cell. 2020 Aug 6;182(3):713-721.e9
pubmed: 32778225
Clin Exp Vaccine Res. 2013 Jul;2(2):97-105
pubmed: 23858400
Nature. 2020 Oct;586(7830):583-588
pubmed: 32731257
Curr Treat Options Allergy. 2020 May 8;:1-19
pubmed: 32391242
Microbes Infect. 2020 Jul - Aug;22(6-7):231-235
pubmed: 32387332
J Infect Dis. 2013 Jan 15;207(2):240-7
pubmed: 23125444
Nat Commun. 2020 May 20;11(1):2601
pubmed: 32433465
Ther Deliv. 2020 Apr;11(4):245-268
pubmed: 32397911
Immunobiology. 2020 May;225(3):151955
pubmed: 32517882
mSphere. 2020 May 13;5(3):
pubmed: 32404514
Science. 2020 Aug 14;369(6505):806-811
pubmed: 32434945
IEEE/ACM Trans Comput Biol Bioinform. 2018 Jul-Aug;15(4):1344-1350
pubmed: 28574363
J Biomed Sci. 2010 Nov 22;17:88
pubmed: 21092195
J Med Virol. 2020 May;92(5):495-500
pubmed: 32022276
Int J Mol Med. 2020 Jul;46(1):3-16
pubmed: 32377694
Vaccines (Basel). 2014 Jul 29;2(3):624-41
pubmed: 26344749
Int J Biol Sci. 2020 Mar 15;16(10):1753-1766
pubmed: 32226295
Front Immunol. 2019 Mar 27;10:594
pubmed: 30972078
Nat Commun. 2016 Nov 22;7:13473
pubmed: 27874853
Front Immunol. 2016 Jun 21;7:243
pubmed: 27446074
NPJ Vaccines. 2020 May 25;5(1):42
pubmed: 32509338
Mol Biol. 2019;53(3):323-334
pubmed: 32214478
Lancet. 2020 Nov 14;396(10262):1595-1606
pubmed: 33065034
Asian Pac J Allergy Immunol. 2020 Mar;38(1):1-9
pubmed: 32105090
Lancet Glob Health. 2018 Dec;6(12):e1386-e1396
pubmed: 30342925
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
J Med Virol. 2020 May;92(5):479-490
pubmed: 32052466